Biotech

All Articles

Vaccine and Keytruda combination effective in squamous cell carcinoma

.Invulnerable gate preventions are the superheroes of cancer cells treatment. Drugs like Bristol Mye...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings as...

Regeneron's Opdualag competitor shows 57% response price

.Regeneron is back along with long-term follow-up for its LAG-3 inhibitor and also PD-1 inhibitor co...

AstraZeneca blog posts records on in-house opponents to AbbVie, Pfizer ADCs

.AstraZeneca has actually discussed an early consider the performance of its own in-house antibody-d...

iTeos- GSK's TIGIT celebrity reveals meaningful improvement

.After revealing a period 3 launch based upon positive midstage end results, iTeos as well as GSK ar...

More joint FDA may increase rare disease R&ampD: report

.The FDA needs to be a lot more open and also collective to let loose a surge in commendations of un...

Zenas, MBX, Bicara scalp to Nasdaq in very hot time for biotech IPOs

.It is actually an abnormally occupied Friday for biotech IPOs, with Zenas BioPharma, MBX as well as...

Atea's COVID antiviral falls short to stop hospitalizations in stage 3

.Atea Pharmaceuticals' antiviral has stopped working one more COVID-19 trial, however the biotech st...

Neurocrine's bid to spare mental illness prospect stops working

.Neurocrine Biosciences' mental illness system pivot has stopped working. The biotech was actually u...

Sanofi pays out $110M upfront for late-stage radioligand treatment

.Sanofi has created a late access to the radioligand party, spending one hundred thousand europeans ...